Allergy immunotherapy market accounted for a market value of US$ 1,953.1 Mn in 2020 and projected to grow at a CAGR of 10.1% during the forecast period from 2025 to 2033. Allergy immunotherapy helps to prevent or minimize the allergic reactions and provide log-term benefit to patients. This therapy helps to increase immunological tolerance and changes the course of disease due to which demand for immunotherapy is increasing globally.
Cutaneous mastocytosis treatment market accounted for a market value of US$ 230.27 Mn in 2021 and projected to grow at a CAGR of 5.6% during the forecast period from 2025 to 2033. Cutaneous mastocytosis is a rare disease in which uncontrolled production of mast cells leads to skin complications such as lesions, blisters, and rashes with aggravated itching.
The Intravitreal injectables market will be showcasing stable growth at a compound annual growth rate (CAGR) of 4.8% during the forecast period from 2025 to 2033. According to the statistics provided by World Health Organization (WHO) approximately 1.3 billion people throughout the globe are suffering with some form of blindness caused majorly due to macular degeneration, diabetic retinopathy, ocular vein occlusions, endophthalmitis and retinitis. Intravitreal injections are being preferred over other treatment options for treating disease associated visual impairment.
Bronchitis treatment market accounted for a market value of US$ 3,509.7 Mn in 2021 and is projected to grow at a CAGR of 4.9% during the forecast period from 2025 to 2033. Bronchitis treatment market is growing gradually throughout the forecast period due to strong product pipeline equipped with target-specific drugs, and rising prevalence & awareness related to the treatment & diagnosis of bronchitis. The major cause of bronchitis is frequent cigarette smoking coupled with exposure to air pollutants.
Hemorrhoids are characterized by swelling and inflammation of veins in the anal canal and cause irritation, pain and itching to the patients. At present, several sufferers seek relief with an assortment of products such as home remedies, topical ointments of varying strengths and compositions. Direct application products offer temporary relief and have to be used for a limited period.
Veterinary pain management market accounted for a market projected to grow at a CAGR of 7.9% during the forecast period from 2025 to 2033. Rising humanization of animals due to developing trend of nuclear family, continuous development in the research & development activities related to the veterinary pain management, and scheduled diagnostics sessions for livestock to maintain the quality of the meat, milk and other products. Improper feeding and unorganized health management of pets & livestock animals leads to obesity and finally leading to joint pain and other disorders. In addition to that, pet and livestock owners are also being counselled & trained by non-government organizations or veterinary doctors to manage health of animals.
The soy lecithin market expected to reach US$ 1.51 Bn in 2033 growing at a CAGR of 5.8% during the forecast period from 2025 to 2033. Soy lecithin is a food additive sourced from soy. It acts as an emulsifier or lubricant when added to food. It is one of the most widely used food additive in the market.
Anemia treatment drugs market accounted for a market value of US$ 38,345.2 Mn in 2021 and projected to grow at a CAGR of 16.4% during the forecast period from 2025 to 2033. An abnormal decrease in the level of red blood cells, irregular red blood cell morphology, or inadequate concentration of haemoglobin in the blood results in anemia.
Microplate instrumentation are important devices used in cell culture and other research. Initially used only in research settings, these equipment have witnessed adoption in disease diagnostics, and therefore in diagnostic laboratories and hospitals. Microplate instrumentation and supplies are laboratory equipment used for understanding the discovery and development of drugs, and assessing the biological, chemical and physical reactions in any research. Microplate systems and supplies are therefore imperative in testing processes such as gene expression, toxicity, protein quantification, and biological reactions.
The diaphragm pumps market is set to grow from US$ 4,177.5 Mn to US$ 6,706.2 Mn at a compounded annual growth rate of 5.4% from 2018 to 2026. Diaphragm pumps are employed for pumping fluids by reciprocating the motion of diaphragm. Rampant growth in industrial sector and increasing production in food and beverage industry drive the diaphragm pumps market growth.
The drugs by therapeutic area include therapy for oncology, cardiovascular, central nervous system, infectious diseases, respiratory, and others. The therapeutic area represents the specific area of medicine where the drug is intended to be used, based on its mechanism of action and intended clinical use. One of the primary drivers of the drugs by therapeutic area market is the increasing prevalence of diseases worldwide. Chronic diseases such as cancer, cardiovascular diseases, and neurological disorders are a significant burden on healthcare systems globally. There is an urgent need for new and effective therapies to treat these diseases, which has led to the growth of the drugs in the therapeutic area market.
The revenues generated by the drugs in the therapeutic area market have been consistently high over the years. The global pharmaceutical market is expected to reach USD 1.5 trillion by 2023, with oncology being the leading therapeutic area. The increasing demand for new therapies, coupled with advancements in technology and an increasing focus on personalized medicine, is expected to drive the growth of the market in the coming years. One of the emerging trends in the drugs by therapeutic area market is the increasing use of precision medicine. Precision medicine involves tailoring medical treatments to individual patients based on their unique genetic and molecular profiles. The development of precision medicine requires the use of advanced diagnostic tools and drug discovery technologies, which have contributed to the growth of drugs in the therapeutic area market.
Another trend in the drugs by therapeutic area market is the increasing focus on biologics. Biologics are drugs that are produced from living cells and are used to treat a wide range of diseases, including cancer and autoimmune disorders. Biologics are more complex than traditional small-molecule drugs, and their development requires specialized manufacturing processes and clinical trial design. The increasing demand for biologics has contributed to the growth of the drugs by therapeutic area market. The increasing focus on rare diseases is also driving the growth of the drugs by therapeutic area market. Rare diseases are defined as diseases that affect fewer than 200,000 people in the United States. Although each rare disease affects a small number of people, there are over 7,000 rare diseases, which together affect millions of people worldwide. There is an urgent need for new therapies to treat rare diseases, which has led to the growth of drugs in the therapeutic area market.
The increasing use of combination therapies is driving the growth of the drugs by therapeutic area market. Combination therapies involve the use of two or more drugs to treat a disease. Combination therapies can improve patient outcomes by targeting multiple pathways involved in the disease process. The development of combination therapies requires the use of advanced drug discovery technologies and clinical trial design, which has contributed to the growth of the drugs by therapeutic area market. The increasing prevalence of diseases worldwide, advancements in technology, and the emerging trends in precision medicine, biologics, rare diseases, and combination therapies are expected to drive the growth of the drugs by therapeutic area market.
